William Blair & Company
EVH icon

William Blair & Company’s Evolent Health EVH Stock Holding History

William Blair & Company’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-800
Closed -$18K – 1637
2017
Q1 		$18K Buy
+800
New +$15.4K ﹤0.01% 1385

Other funds holding EVH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

William Blair & Company's EVH Position: Q2 2026 in Review

William Blair & Company increased its Evolent Health (EVH) stake by 3.5% in Q2 2026, buying an estimated $4.64K and bringing the position to 36,249 shares worth $196K. The position accounts for ﹤0.01% of the portfolio, ranked #1582.

William Blair & Company first reported a position in EVH in Q1 2016 and has held it in 42 quarters since. The position peaked at $107M in Q1 2024. 198 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

  • William Blair & Company held 36,249 shares of Evolent Health worth $196K as of Q2 2026.
  • William Blair & Company bought 1,210 Evolent Health shares in Q2 2026, an estimated $4.64K.
  • Evolent Health made up ﹤0.01% of William Blair & Company's portfolio in Q2 2026, its #1582 holding.
  • William Blair & Company first reported a position in Evolent Health in Q1 2016 and has held it in 42 quarters since.
  • William Blair & Company's Evolent Health position peaked at $107M in Q1 2024.
  • 198 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on William Blair & Company's 13F filing for Q2 2026, filed 11 Aug 2026.